Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Liabilities and Shareholders Equity (2016 - 2025)

Harte Hanks (HHS) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $92.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 14.26% to $92.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $390.1 million, a 14.09% decrease, with the full-year FY2024 number at $101.8 million, down 17.09% from a year prior.
  • Liabilities and Shareholders Equity was $92.7 million for Q3 2025 at Harte Hanks, down from $95.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $122.8 million in Q4 2023 to a low of $92.7 million in Q3 2025.
  • A 5-year average of $110.1 million and a median of $111.1 million in 2022 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 11.24% in 2022, then decreased 17.09% in 2024.
  • Harte Hanks' Liabilities and Shareholders Equity stood at $107.9 million in 2021, then rose by 11.24% to $120.0 million in 2022, then rose by 2.31% to $122.8 million in 2023, then fell by 17.09% to $101.8 million in 2024, then fell by 8.92% to $92.7 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Liabilities and Shareholders Equity are $92.7 million (Q3 2025), $95.0 million (Q2 2025), and $100.6 million (Q1 2025).